| AFC-HD AMS Life Science Co. Ltd. also released the following forecasts: | |
| GROUP | Year Ending |
| Aug 2025 | |
| Revenue | Y31.10 bln |
| Operating Profit | Y2.20 bln |
| Pretax Profit | Y2.20 bln |
| Net Profit | Y1.32 bln |
| Per share | |
| Earnings | Y93.78 |
| Results are based on Japanese accounting standards. |
(END) Dow Jones Newswires
| AFC-HD AMS Life Science Co. Ltd. (2927.TO) | ||
| Japan | ||
| Nine Months Ended May 31 | ||
| GROUP | 2025 | 2024 |
| Revenue | Y24.74 bln | Y22.34 bln |
| Operating Profit | Y1.85 bln | Y1.50 bln |
| Pretax Profit | Y1.87 bln | Y1.51 bln |
| Net Profit | Y1.41 bln | Y922.00 mln |
| Per share | ||
| Earnings | Y100.42 | Y65.78 |
| Diluted Earnings | Y100.41 | Y65.71 |
| Results are based on Japanese accounting standards. |
This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.
(END) Dow Jones Newswires
July 10, 2025 02:30 ET (06:30 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.